poisar

Stock

Milestone Pharmaceuticals Inc. MIST

$1.65-3.80%

Overview

MIST market data

Price History

MIST price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.75
Diluted earnings per share over the trailing twelve months.
Beta
0.98
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.00 – $3.06
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $150.6 · P/B 4.12 · P/S 84.44.

Company news

10 captured
8-K filing — Milestone Pharmaceuticals Inc. (MIST)SEC EDGAR · Jun 15, 2026, 8:05 PM
Wells Fargo Maintains Overweight on Milestone Pharmaceuticals, Lowers Price Target to $7Benzinga · May 14, 2026, 2:24 PM
Milestone Pharmaceuticals May Offer Up To $100M Common Shares Via Cantor Fitzgerald Sales AgreementBenzinga · May 13, 2026, 9:36 PM
Milestone Pharmaceuticals Files Prospectus To Offer Securities Up To $300MBenzinga · May 13, 2026, 9:34 PM
Milestone Reports Q1 Results, Highlights Initial CARDAMYST SalesBenzinga · May 13, 2026, 2:04 PM
Milestone Pharmaceuticals Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 13, 2026, 1:40 PM
Milestone Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS results.Benzinga · May 13, 2026, 1:26 PM
Milestone Expands CARDAMYST Push Into Europe, China And New AFib TrialBenzinga · May 13, 2026, 11:13 AM
Earnings Scheduled For May 13, 2026Benzinga · May 13, 2026, 11:11 AM
Milestone Pharmaceuticals Q1 EPS $(0.20) Misses $0.14 Estimate, Sales $238.000KBenzinga · May 13, 2026, 11:06 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock